345 related articles for article (PubMed ID: 30293781)
21. Phospholipase D2-derived phosphatidic acid binds to and activates ribosomal p70 S6 kinase independently of mTOR.
Lehman N; Ledford B; Di Fulvio M; Frondorf K; McPhail LC; Gomez-Cambronero J
FASEB J; 2007 Apr; 21(4):1075-87. PubMed ID: 17242159
[TBL] [Abstract][Full Text] [Related]
22. AMOTL1 Promotes Breast Cancer Progression and Is Antagonized by Merlin.
Couderc C; Boin A; Fuhrmann L; Vincent-Salomon A; Mandati V; Kieffer Y; Mechta-Grigoriou F; Del Maestro L; Chavrier P; Vallerand D; Brito I; Dubois T; De Koning L; Bouvard D; Louvard D; Gautreau A; Lallemand D
Neoplasia; 2016 Jan; 18(1):10-24. PubMed ID: 26806348
[TBL] [Abstract][Full Text] [Related]
23. Intercalated disc protein Xinβ is required for Hippo-YAP signaling in the heart.
Guo H; Lu YW; Lin Z; Huang ZP; Liu J; Wang Y; Seok HY; Hu X; Ma Q; Li K; Kyselovic J; Wang Q; Lin JL; Lin JJ; Cowan DB; Naya F; Chen Y; Pu WT; Wang DZ
Nat Commun; 2020 Sep; 11(1):4666. PubMed ID: 32938943
[TBL] [Abstract][Full Text] [Related]
24. Rho differentially regulates the Hippo pathway by modulating the interaction between Amot and Nf2 in the blastocyst.
Shi X; Yin Z; Ling B; Wang L; Liu C; Ruan X; Zhang W; Chen L
Development; 2017 Nov; 144(21):3957-3967. PubMed ID: 28947533
[TBL] [Abstract][Full Text] [Related]
25. Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling.
Wu J; Minikes AM; Gao M; Bian H; Li Y; Stockwell BR; Chen ZN; Jiang X
Nature; 2019 Aug; 572(7769):402-406. PubMed ID: 31341276
[TBL] [Abstract][Full Text] [Related]
26. Phospholipase D activates HIF-1-VEGF pathway via phosphatidic acid.
Han S; Huh J; Kim W; Jeong S; Min do S; Jung Y
Exp Mol Med; 2014 Dec; 46(12):e126. PubMed ID: 25523098
[TBL] [Abstract][Full Text] [Related]
27. The regulation and function of YAP transcription co-activator.
Zhu C; Li L; Zhao B
Acta Biochim Biophys Sin (Shanghai); 2015 Jan; 47(1):16-28. PubMed ID: 25487920
[TBL] [Abstract][Full Text] [Related]
28. Phospholipase D and phosphatidic acid in plant defence response: from protein-protein and lipid-protein interactions to hormone signalling.
Zhao J
J Exp Bot; 2015 Apr; 66(7):1721-36. PubMed ID: 25680793
[TBL] [Abstract][Full Text] [Related]
29. Osmotic stress-induced phosphorylation by NLK at Ser128 activates YAP.
Hong AW; Meng Z; Yuan HX; Plouffe SW; Moon S; Kim W; Jho EH; Guan KL
EMBO Rep; 2017 Jan; 18(1):72-86. PubMed ID: 27979971
[TBL] [Abstract][Full Text] [Related]
30. Understanding of the roles of phospholipase D and phosphatidic acid through their binding partners.
Jang JH; Lee CS; Hwang D; Ryu SH
Prog Lipid Res; 2012 Apr; 51(2):71-81. PubMed ID: 22212660
[TBL] [Abstract][Full Text] [Related]
31. Viral small T oncoproteins transform cells by alleviating hippo-pathway-mediated inhibition of the YAP proto-oncogene.
Nguyen HT; Hong X; Tan S; Chen Q; Chan L; Fivaz M; Cohen SM; Voorhoeve PM
Cell Rep; 2014 Aug; 8(3):707-13. PubMed ID: 25088426
[TBL] [Abstract][Full Text] [Related]
32. Phosphatidic acid-producing enzymes regulating the synaptic vesicle cycle: Role for PLD?
Barber CN; Huganir RL; Raben DM
Adv Biol Regul; 2018 Jan; 67():141-147. PubMed ID: 28986032
[TBL] [Abstract][Full Text] [Related]
33. Proliferative and metastatic roles for Phospholipase D in mouse models of cancer.
Roth E; Frohman MA
Adv Biol Regul; 2018 Jan; 67():134-140. PubMed ID: 29154090
[TBL] [Abstract][Full Text] [Related]
34. DLGAP1-AS2-Mediated Phosphatidic Acid Synthesis Activates YAP Signaling and Confers Chemoresistance in Squamous Cell Carcinoma.
Nan Y; Luo Q; Wu X; Liu S; Zhao P; Chang W; Zhou A; Liu Z
Cancer Res; 2022 Aug; 82(16):2887-2903. PubMed ID: 35731019
[TBL] [Abstract][Full Text] [Related]
35. mTOR signaling: PLD takes center stage.
Sun Y; Chen J
Cell Cycle; 2008 Oct; 7(20):3118-23. PubMed ID: 18927511
[TBL] [Abstract][Full Text] [Related]
36. Imaging and Editing the Phospholipidome.
Chiu DC; Baskin JM
Acc Chem Res; 2022 Nov; 55(21):3088-3098. PubMed ID: 36278840
[TBL] [Abstract][Full Text] [Related]
37. A Repertoire of MicroRNAs Regulates Cancer Cell Starvation by Targeting Phospholipase D in a Feedback Loop That Operates Maximally in Cancer Cells.
Fite K; Elkhadragy L; Gomez-Cambronero J
Mol Cell Biol; 2016 Jan; 36(7):1078-89. PubMed ID: 26787840
[TBL] [Abstract][Full Text] [Related]
38. Phospholipase D stabilizes HDM2 through an mTORC2/SGK1 pathway.
Lyo D; Xu L; Foster DA
Biochem Biophys Res Commun; 2010 May; 396(2):562-5. PubMed ID: 20438709
[TBL] [Abstract][Full Text] [Related]
39. NF2 and Canonical Hippo-YAP Pathway Define Distinct Tumor Subsets Characterized by Different Immune Deficiency and Treatment Implications in Human Pleural Mesothelioma.
Yang H; Hall SRR; Sun B; Zhao L; Gao Y; Schmid RA; Tan ST; Peng RW; Yao F
Cancers (Basel); 2021 Mar; 13(7):. PubMed ID: 33805359
[TBL] [Abstract][Full Text] [Related]
40. Phosphatidic acid signaling to mTOR: signals for the survival of human cancer cells.
Foster DA
Biochim Biophys Acta; 2009 Sep; 1791(9):949-55. PubMed ID: 19264150
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
